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ABSTRACT Evidence supports the expression of
brain-type sodium channels in the heart. Their func-
tional role, however, remains controversial. We used
global NaV1.6-null mice to test the hypothesis that
NaV1.6 contributes to the maintenance of propagation
in the myocardium and to excitation-contraction (EC)
coupling. We demonstrated expression of transcripts
encoding full-length NaV1.6 in isolated ventricular myo-
cytes and confirmed the striated pattern of NaV1.6
fluorescence in myocytes. On the ECG, the PR and
QRS intervals were prolonged in the null mice, and the
Ca2 transients were longer in the null cells. Under
patch clamping, at holding potential (HP)  120 mV,
the peak INa was similar in both phenotypes. However,
at HP  70 mV, the peak INa was smaller in the nulls.
In optical mapping, at 4 mM [K]o, 17 null hearts
showed slight (7%) reduction of ventricular conduction
velocity (CV) compared to 16 wild-type hearts. At 12
mM [K]o, CV was 25% slower in a subset of 9 null vs.
9 wild-type hearts. These results highlight the impor-
tance of neuronal sodium channels in the heart,
whereby NaV1.6 participates in EC coupling, and rep-
resents an intrinsic depolarizing reserve that contrib-
utes to excitation.—Noujaim, S. F., Kaur, K., Milstein,
M., Jones, J. M., Furspan, P., Jiang, D., Auerbach, D. S.,
Herron, T., Meisler, M. H., Jalife, J. A null mutation of
the neuronal sodium channel NaV1.6 disrupts action
potential propagation and excitation-contraction cou-
pling in the mouse heart. FASEB J. 26, 63–72 (2012).
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Channelopathies are an increasingly recognized
category of inherited human diseases (1, 2). Missense
mutations of Na-channel genes have been linked not
only to cardiac ion-channel diseases (1, 2) but also to
epilepsy, chronic pain, and motor disorders (3, 4). A
rare heterozygous null mutation of human SCN8A,
which encodes the sodium channel NaV1.6, was identi-
fied in a 9-yr-old boy with mental retardation, pancer-
ebellar atrophy, and ataxia; 3 additional heterozygotes
in the same family exhibited milder cognitive and
behavioral defects, including attention deficit hyperac-
tivity disorder (5). However, no studies have been
reported to assess the possibility that mutation of
NaV1.6 produces adverse consequences in cardiac elec-
trical function.
There are 9 genes for functional voltage-gated sodi-
um-channel  subunits in the human genome (6).
Several of these genes, including brain-type genes, are
expressed in the heart, and the Na-channel subtypes
are differentially localized and appear to have differ-
ences in functional properties (6, 7). Structurally, Na
channels are complexes of a 260-kDa  subunit in
association with smaller  subunits of 33–36 kDa (8).
The NaV1.5 sodium-channel gene is strongly expressed
in the heart, and for many years it was thought to be
exclusively responsible for generating the upstroke of
the normal cardiac action potential. However, it has
recently become evident that neuronal and skeletal
muscle Na-channel isoforms are also expressed at low
levels in the heart and may contribute to cardiac
function (3). Immunolocalization studies have revealed
distinct subcellular localization of the various  and 
subunits, and it has been proposed that the primary
Na channels in ventricular myocytes are composed of
NaV1.5 plus 2 and/or 4 subunits in intercalated
disks, in addition to NaV1.1, NaV1.3, and NaV1.6 plus 1
and/or 3 subunits in the transverse tubules (9, 10).
Functionally, brain-type Na channels are thought to
be involved in excitation-contraction (EC) coupling by
synchronizing the action potential in the sarcolemmal
of the t tubules (11). Such a role, however, remains
controversial (12). On the other hand, it has been
suggested that tetrodotoxin (TTX)-sensitive brain-type
Na channels contribute to automaticity of sinoatrial
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nodal cells of the mouse heart and may have a role in
sinoatrial dysfunction (13). Recently it was shown that
NaV1.1 and NaV1.6 are the primary Na
-channel sub-
units in the rat sinus node and that heart failure results
in their down-regulation (14).
The individual cardiac contributions of NaV1.1,
NaV1.3, and NaV1.6 were not distinguished in previous
studies, which were carried out in wild-type animals
expressing all 3 neuronal channels.
Several global-null mutants of Scn8a lacking the
NaV1.6 channel in all tissues have been described (15).
NaV1.6-null mice exhibit neurological deficits, includ-
ing tremor, ataxia, and hindlimb paralysis, and do not
survive beyond 3 wk of age. Impaired repetitive firing
has been shown in cerebellar Purkinje cells and other
types of neurons. Reduced size of the heart was de-
scribed in the null mutant Scn8admu, but electrophysio-
logical studies of cardiac function were not carried out
(16, 17). We have used the ENU-induced null mutant
Scn8aS21P (18) to determine the consequences of
NaV1.6 reduction on cardiac electrical function and EC
coupling. In the ataxia 3 mutant mice, chromosomal
mapping of the mutant phenotype and allelism testing
demonstrated that the mutation is an allele of Scn8a
(18). Sequencing of the Scn8a brain transcript identi-
fied the nucleotide change that resulted in the amino
acid substitution S21P (18). The effect of this mutation
is to trap the Nav1.6 protein in the Golgi, resulting in
the absence of channel activity (18). Our approach
utilized biochemistry, calcium imaging, patch clamp-
ing, and optical mapping to test the hypothesis that
NaV1.6 participates in EC coupling and represents an
intrinsic depolarizing reserve that contributes to the
maintenance of cardiac excitation.
MATERIALS AND METHODS
Animals
Experiments were carried out with the approval of the Unit of
Laboratory Animal Resources at the University of Michigan.
Wild-type (WT) littermate and null mice between 19 and 21 d
of age were used in this study. Before removal of the heart via
thoracotomy, the mice were heparinized (5 U/g, i.p.) and
then deeply anesthetized with Avertin (0.05 ml/g, i.p.).
NaV1.6 mRNA analysis by RT-PCR and sequencing
Hearts were removed and washed in RNase/DNase free
ice-cold PBS. Isolated hearts were saved in RNA stabilizing
agent (Ambion, Austin, TX, USA) until further use. For
isolated cells, the myocytes were allowed to attach on laminin-
coated dishes for 2 h to remove nonmyocytes. After 2 h,
cardiac myocytes were washed with PBS and lysed with lysis
buffer to isolate RNA and analyze the expression of NaV1.6
transcript. Isolated RNA was treated with DNase. cDNA was
synthesized from 2 g of total RNA with Oligo dT primers
using the SuperScript III First-Strand Synthesis System from
Invitrogen (Carlsbad, CA, USA) and then subjected to PCR
using Clontech titanium taq PCR Kit (Clontech, Mountain View,
CA, USA). Sense (5-AAGTGGACAGCCTATGGCTTCGTC-
3) and antisense (5-AGCCAGAAGATGAGACACACCAGC-
3) primers (5 pmol) for NaV1.6 were used in PCR. These
primers terminate on nucleotides that are specific for this
member of the sodium-channel family and amplify a cDNA
fragment containing exons 17–19. No-template controls and
no-RT controls were run during each experiment to detect any
RNA and/or DNA contamination. Samples were denatured at
94°C for 1 min, followed by 35 cycles of denaturation at 94°C for
30 s, annealing at 60°C for 30 s, and extension at 68°C for 1 min,
then a final extension at 68°C for 3 min. The PCR product (5 l)
was analyzed on a 2% agarose gel by electrophoresis. The PCR
product was cleaned and sequenced using above-mentioned prim-
ers for NaV1.6 at the University of Michigan DNA sequencing core.
Mouse ventricular myocyte isolation
On removal of the heart, we proceeded with the enzymatic
digestion of the lower 2/3 ventricular region (apex), as de-
scribed previously (19). Myocytes were resuspended in buffer
containing 10% bovine calf serum and CaCl2 (12.5 M), and
[Ca2] was increased to 1 mM. Cells were used for morpholog-
ical assessment, immunohistochemistry, electrophysiological re-
cording, and Ca2 imaging within 8 h after isolation.
Cell size measurement
Morphological measurements (length, width) of plated cells
were collected using digital photomicroscopy and the imaging
program AxioVision (Zeiss) on a Zeiss inverted microscope with
a10 or20 objective (Carl Zeiss, Oberkochen, Germany). No
significant differences were observed in length or width between
live and fixed cells for any of the groups; all subsequent measure-
ments were then conducted on fixed cells. Cells were selected for
measurement if they showed no obvious sign of damage.
Immunocytochemistry
Isolated cells were plated on laminin-coated glass coverslips,
fixed with 4% paraformaldehyde (10 min), permeabilized with
0.1% Triton X-100, and washed with PBS. For sections, hearts
were incubated in 30% sucrose solution overnight at 4°C.
Endogenous mouse immunoglobulin was blocked using a
mouse-on-mouse (anti-mouse Ig) blocking reagent (M.O.M. kit;
Vector Laboratories, Burlingame, CA, USA) for 1 h at room
temperature. Cells were further blocked for 1 h with 5% normal
donkey serum in PBS (containing 0.1% Triton X-100), and
subsequently incubated with primary antibodies overnight at
4°C. After washing, donkey secondary antibodies (anti-mouse
and anti-rabbit) conjugated to DyLight fluorophores (488, 549;
Jackson ImmunoResearch Laboratories, West Grove, PA, USA)
were added for 1 h. Nuclei were stained with 100 M 4-6-
diamidino-2-phenylindole (DAPI) and washed, and coverslips
were mounted to microscope slides using ProLong Gold Anti-
Fade Mounting Kit (Molecular Probes, Eugene, OR, USA).
Immunofluorescence was examined with a Nikon Eclipse Ti
inverted confocal microscope with a 63/1.2-NA oil objective
(Nikon Inc., Tokyo, Japan), at ambient temperature. Noncon-
focal images were obtained using conventional fluorescence
with the Apotome system (Zeiss). The antibodies used were
rabbit anti-NaV1.6 (Alomone, Jerusalem, Israel) and monoclo-
nal anti-sarcomeric alpha actinin (Sigma-Aldrich, St Louis, MO,
USA). In neurons from Scn8a-null mice, the Alomone antibody
cross-reacts with the other abundant neuronal sodium channels
(18), but in cardiomyoctes, we observed specific staining of
NaV1.6 (see below).
Patch-clamp experiments
Whole-cell membrane currents were recorded from ventricu-
lar myocytes at room temperature (20–22°C) using the patch
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clamp (Axopatch 700B amplifier; Axon Instruments, Foster
City, CA, USA); settings and properties have been described
elsewhere (20, 21). In one set of experiments, INa was
measured in low [Na]o (5 mM) to reduce INa and improve
voltage control. Low-resistance (1.60.1 M	) patch pipettes
were used. Access resistance was compensated to 1–2 M	.
Input resistance was 0.4–1 G	. Appropriate whole-cell capac-
itance and series resistance compensation were applied,
along with leak subtraction. Brain-type sodium channels have
steady-state inactivation and activation curves between 15 and
25 mV more positive than NaV1.5 (22). Thus, brain-type
sodium channels have greater availability at depolarized
ranges of membrane potential. For I-V relationships, cells
were held at different holding potentials (HP; 
120 and 
70
mV) and stepped to a range of potentials (
100 to 30 mV
in 5-mV increments for HP
120 mV, and 
60 to 30 mV
for HP
70 mV) for 100 ms each. In a second set of
experiments, 100 nM TTX-sensitive sodium currents (brain-
type isoforms) were measured at 50 mM [Na]o and at the
holding potential of 
70 mV, in the presence of 1 mM Cd2
to selectively block NaV1.5 (23). In a subset of these experi-
ments, [TTX] was increased to 1 M.
ECG recording
Lead II ECG in restrained, conscious animals was recorded
and digitized (1.2 kHz) using custom-made software in Lab-
View (National Instruments, Austin, TX, USA) and a Biopac
Systems amplifier (DA100C) and digitizer (IPS100C; Biopac
Systems, Santa Barbara, CA, USA).
Optical mapping of the whole heart
The heart was rapidly excised through thoracotomy, con-
nected to a Langendorff-perfusion system, and perfused with
warm oxygenated Tyrode’s solution as described earlier (24–
26) and allowed to equilibrate for 10 min. We used Di-4-
ANEPPS and a CCD camera (6464 pixel; spatiotemporal
resolution 109 m, 1 kHz) and mapped the epicardial
anterior surfaces of the ventricles. Further details have been
presented elsewhere (24–27). Here, 7 M blebbistatin was
used to prevent contraction. Sixteen WT and 17 null hearts
were initially perfused with 4 mM [K]o Tyrode’s solution. In
a subset of 9 hearts in both phenotyopes, the [K]o was raised
to 8, 10, and 12 mM, for 15 min at each [K]o. At the ends of
the 15-min periods, pacing was done with a bipolar, silver-tip
stimulation electrode placed on the apex (3-ms pulses, 2
diastolic threshold, cycle lengths of 140 and 80 ms), and
movies were recorded. We generated activation and APD
maps by calculating, for each pixel, the activation time or the
APD at 80% repolarization during pacing at 140 and 80 ms.
To compute CV, the magnitude of local conduction vectors
was determined on the basis of the activation times of
surrounding pixels as described elsewhere (24).
Calcium imaging
Briefly, cell suspensions were incubated with cell-permeant
rhod-2AM calcium indicator (10 M; Molecular Probes) for
10 min at room temperature and then washed to remove
excess dye. Fluorescence was expressed as F/F0  (F 
 F0/
F0), where F is the fluorescence at any given time and F0 is the
baseline fluorescence value. Nonconfocal calcium was im-
aged at 200 Hz in individual cells using an inverted Zeiss
microscope equipped with temperature control and a Red-
shirt Imaging camera (Redshirt Imaging, Decatur, GA, USA).
The cells were paced at 1 Hz.
Statistics
One-way ANOVA with Bonferroni correction and t test were
used as appropriate. For the hyperkalemia experiments,
we used the Multivariate Mixed procedure in the SAS package
(SAS Institute, Cary, NC, USA) in consultation with the
University of Michigan Center for Statistical Consultation and
Research. We indicate in the text and figure legends the
statistical test used and whether data are averages  se or sd.
RESULTS
Morphological assessment
Macroscopic examination revealed that NaV1.6-null
hearts were small compared with WT littermates at 18 d
of age. Previous studies noted that the reduction in
heart size is proportional to the overall reduction in
body weight (16, 17). Since NaV1.6 is a neuronal
sodium channel, we investigated whether the nerve
supply to the ventricles was altered in the null hearts
compared to WT littermates using acetylcholinesterase
precipitation reaction (28). Macroscopically, the epi-
cardial innervation of 4 null hearts did not appear to be
altered when compared with 4 WT hearts (data not
shown). On the other hand, the ventricular myocytes of
the null mouse (Fig. 1Ab) were appreciably smaller
than those of WT littermates (Fig. 1Aa). Morphometric
quantification demonstrated that the ventricular cardio-
myocytes of 4 null hearts had significantly reduced
length (Fig. 1Ac) and width (Fig. 1Ad) compared to 3
WT hearts. Figure 1B compares representative confocal
images of the t-tubule network of littermate WT and
null myocytes. The images of these live myocytes were
stained with wheat-germ agglutinin (Fig. 1Ba, b) or the
lipophilic dye di-8-ANEPPS (Fig. 1Bc, d). Figure 1Be, f
shows fluorescence intensity profiles along the longitu-
dinal axis of each cell stained with di-8-ANEPPS. Figure
1Bg, h shows the respective spectra obtained by fast
Fourier transformation of the fluorescence profiles.
The t-tubule network is apparent in both WT and null
cardiomyocytes, with a regular fluorescence profile
(peaks at 2 m intervals). This pattern was similar in
cells from 3 WT and 3 null hearts and is consistent with
other studies in rodents (29). In addition, membrane
capacitance was decreased in null (722.3 pF) com-
pared to WT (835.4 pF; P  0.05; N4, n10); the
resting membrane potential in WT was 
77.25  0.76
(N3, n6) and in null 
75.13  1.18 (N3, N6).
Characterization of Scn8a transcripts in the heart
The Scn8a gene contains alternative exons 18N and 18A
that exhibit tissue-specific splicing (30). Transcripts
containing exon 18A encode the full-length channel
and in previous studies were shown to be restricted to
brain. Because of the in-frame stop codon in exon 18N,
transcripts in non-neural cells encode a truncated,
2-domain protein (30). This alternative splicing pattern
was thought to restrict active NaV1.6 channels to neu-
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rons; however, Scn8a transcripts in heart have not
previously been characterized. To specifically amplify
NaV1.6 transcripts in the presence of NaV1.5 and the
other brain-type channels, we designed a gene-specific
forward primer in exon 17 and reverse primer in exon
19 terminating in nucleotides that differ between
NaV1.6 and the other sodium channels. Using these
primers, we detected 3 Scn8a transcripts in heart con-
taining exon 18A, exon 18N, or skipping both (18;
Fig. 2A). The inclusion of exon 18A was confirmed by
sequencing the PCR product isolated from the gel. This
is the first demonstration that NaV1.6 transcripts encod-
ing full-length protein are expressed in the heart and
provides important validation for the detection of
NaV1.6 by immunostaining (see below). We also exam-
ined NaV1.6 transcripts in isolated adult cardiomyo-
cytes. PCR products from isolated myocytes, whole
heart, and brain were amplified from 100 ng of RNA
(Fig. 2B). These data demonstrate directly that full-
length NaV1.6 transcripts are present in the ventricular
myocytes.
Immunolocalization of NaV1.6
Previous studies reported that NaV1.6 protein is local-
ized to the t tubules of the mouse cardiac myocyte, but
these studies did not include the null control to con-
firm the specificity of immunostaining (9, 11). After
confirming the presence of the full-length coding tran-
script of Scn8a in the heart, we conducted immunolo-
calization experiments on WT and mutant heart. Im-
munofluorescence in single cells from WT heart
confirmed the localization of NaV1.6 in a t-tubular
pattern (Fig. 3A, left panel). NaV1.6 immunofluores-
cence is shown in red, and -sarcomeric actinin stain-
ing is shown in green. In WT, but not null, myocytes,
NaV1.6 exhibits a striated staining pattern that colocal-
izes with -actinin (Fig. 3A). In Scn8a-null myocytes, no
specific staining pattern is observed with antibodies for
NaV1.6 although actinin staining is normal (Fig. 3A,
right panel). In addition, the intensity profiles along
the indicated arrows (Fig. 3A) show that NaV1.6 fluo-
rescence pattern colocalizes with that of actinin in an
alternating manner, demonstrating the presence of
NaV1.6 in the t tubules of the WT, but not in the null
myocyte. The confocal microscope laser settings were
identical for all images.
Functional expression of NaV1.6 in the mouse heart
As an initial approximation to estimate the contribu-
tion of NaV1.6 to INa in cardiac ventricular myocytes, we
compared the I-V relations of WT vs. null ventricular
myocytes at 5 mM [Na]o and 2 different HPs: 
120
mV (Fig. 4A) and 
70 mV (Fig. 4B). Our rationale for
these experiments was based on the fact that the range
of inactivation voltages of brain-type Na channels is
significantly more positive than NaV1.5 (3, 22); there-
fore, at 
70 mV, the NaV1.5 channels are largely
inactivated. In Fig. 4A, at HP  
120 mV and 5 mM
[Na]o, peak inward INa was similar in the two pheno-
types. However, at HP  
70 mV (Fig. 4B), the peak
inward INa was smaller in null compared to WT cells
(30.3 pA/pF, N2, n4 vs. 5.50.28 pA/pF, N2,
n5, P0.05, ANOVA). To further distinguish between
NaV1.5 and NaV1.6, we used the channel blocker TTX.
Brain-type Na channels, including NaV1.6, are sensi-
tive to nanomolar blocking concentrations (100 nM) of
Figure 1. Assessment of cardiomyocyte length and width in NaV1.6 mutant and WT mice and the profile of the t-tubular network.
A) a, b) Cell morphology. n  total number of cells from 3 WT (a) and 4 null hearts (b). c, d) Cell length (c) and width (d);
data are averages  se, t test. B) Membrane staining showing t-tubule network in myocytes from WT (a, c, e, g) and from
NaV1.6-null mice (b, d, f, h). a, b) Wheat-germ agglutinin. c, d) Lipophilic dye di-8-ANEPPS. e, f) Fluorescence intensity profiles
along the longitudinal axis of each cell stained with di-8-ANEPPS. g, h) Fast Fourier transformation of the fluorescence profiles.
Scale bars  50 m (A); 20 m (B).
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TTX, whereas cardiac-type channels require TTX con-
centrations in the micromolar range to be fully blocked
(20, 21). On the other hand, NaV1.5 can be readily
blocked by Cd2 at much lower concentrations than
brain-type Na channels (23). Therefore, we con-
ducted a second set of experiments to compare the
density of the TTX-sensitive INa in WT vs. null myocytes
in the continuous presence of 1 mM Cd2, which
enabled us to raise the [Na]o to 50 mM, while still
maintaining voltage control. Before TTX, the peak
inward INa was significantly smaller in null cells (Fig.
4D) than WT cells (Fig. 4C; 3.40.6 pA/pF, N5, n9
vs. 8.91 pA/pF, N4, n10, P0.05, ANOVA). After
addition of 100 nM TTX, the peak currents decreased
to 1.5 0.5 pA/pF in null myocytes (Fig. 4D) and 3.4
0.4 pA/pF in WT (P0.05; Fig. 4C). After addition of 1
M TTX, the current was reduced to 1.5  0.04 pA/pF
(N2, n4) and 1.2  0.01 pA/pF (N3, n5) in WT
and null myocytes, respectively. The V1/2 of inactivation
in WT and null myocytes was 
72.2 and 
73.1 mV,
respectively, and the slope factor was the same in both
phenotypes at 9.3 (Fig. 4E). For activation, the V1/2 and
the slope factor in WT and null myocytes were 
26.8
mV and 27.9 (Fig. 4E). In Fig. 4F, the 100 nM TTX-
sensitive current obtained from the data in Fig. 4C, D
was significantly smaller in null than WT cells (2.60.5
pA/pF vs. 5.80.7 pA/pF, P0.05, ANOVA). Alto-
gether, these experiments support the presence of
functional NaV1.6 channels in the mouse ventricular
myocytes.
Reduced NaV1.6 results in an altered ECG
phenotype
We recorded ECGs (lead II) in nonanesthetized, gently
restrained conscious WT and null mice. Figure 5A
shows representative recordings of a single sinus beat in
a WT mouse (left panel) and in a null mouse (right
panel). The PR interval is prolonged and the QRS is
wider in the null mouse. Superposition of QRS-T
complexes from mice in Fig. 5B illustrates the QRS
prolongation in the NaV1.6 mutant mouse. The bar
graph in Fig. 5C quantifies the PR and QRS intervals
from 8 WT and 9 null mice. Both intervals were
prolonged in the NaV1.6 mutant animals. The PR
interval was 30  3.7 ms in null, compared with 42 
6.7 ms in WT (P  0.05), and the QRS was 15  3.8 ms
Figure 2. Transcripts of Scn8a containing exon 18A and
encoding full-length protein in mouse heart and ventricular
myocytes. A) First-strand cDNA from heart (1 g) and brain
(0.1 g) was amplified by PCR. PCR products (5 l) were
electrophoresed through 2.5% agarose and visualized by
ethidium bromide fluorescence. H1–H3, cDNA from 3 differ-
ent hearts; NTC, no template control; B, brain as a positive
control for the 18A splice form encoding the full-length
NaV1.6 protein (35 cycles). B) Scn8a transcripts in isolated
adult cardiac myocytes (Myo) from WT mouse hearts. Posi-
tions of the RT-PCR products containing exon 18A, 18N, and
skipping exon 18 (18) are shown at right in panel A.
Figure 3. Immunofluorescent patterns of NaV1.6 and actinin. A) Immunofluorescent pattern of NaV1.6 (red) and actinin
(green) in isolated cardiac myocytes from WT and NaV1.6-null mice. Boxed areas are magnified in bottom panels.
B) Fluorescence intensity profiles along arrows in panel A. Scale bars  20 m.
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in WT compared with 20  1.2 ms in null (P0.05,
ANOVA).
NaV1.6 contributes to conduction velocity and action
potential duration in the normal mouse ventricles
In isolated WT and null hearts, we determined the
epicardial conduction velocity (CV) and action po-
tential duration (APD) on the anterior surface of the
ventricles. Hearts were Langendorff perfused with 4
mM K Tyrode’s solution and paced from the apex.
Measurements at 2 different cycle lengths (CLs), 140
and 80 ms, demonstrated small but significant differ-
ences in both CVs between the two groups. At CL 
140 ms, CV was 61.4  7.2 cm/s in WT hearts (n16)
vs. 57.6  4.1 cm/s in null hearts (n17; P0.05,
ANOVA). At CL  80 ms, CV was 57.5  6.8 ms in
WT hearts vs. 53.6  5.2 ms in null hearts (P0.05,
ANOVA). We also quantified APD80. At CL  140 ms,
APD was 41.2  5.5 ms in WT hearts (n16) vs.
45.6  8.2 ms in null hearts (n17; P0.05,
ANOVA). At CL  80 ms, APD was 41.3  5.4 ms in
WT hearts vs. 45.5  5.8 ms in null hearts (P0.05,
ANOVA). The plots of these data are not shown. In
addition, in subset of 9 WT and 9 null hearts, we
investigated the changes in CV and APD as a function
of the extracellular potassium concentration ([K]o), as
described in the following section.
Figure 4. INa measurement. A) Total INa at HP  
120 mV, [Na]o  5mM. B) INa at HP  
70 mV, [Na]o  5mM. C) INa at
HP  
70 mV with 1 mM Cd2, and TTX in WT cells, [Na]o  50 mM. D) INa at HP  
70 mV with 1 mM Cd
2, and TTX
in null cells, [Na]o  50 mM. E) Steady-state inactivation and activation curves of the sodium current at HP  
70 mV, with
1 mM Cd2. F) TTX (100 nM)-sensitive current obtained from panels C, D. Data are averages  sd, ANOVA.
C
Figure 5. ECG recording. A) Representative
recordings of a single sinus beat in a WT
mouse (left panel) and in a null mouse
(right panel). B) Superposition of QRS-T
complexes from mice in panel A. C) NaV1.6
mutant mice exhibit prolonged PR and QRS
intervals. Data are averages  sd, ANOVA.
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Hyperkalemia exaggerates the slowing of CV in
NaV1.6-null mouse hearts
Brain-type sodium channels have more positive activa-
tion threshold and greater availability at depolarized
ranges of membrane potential than NaV1.5. We there-
fore surmised that brain-type sodium channels, includ-
ing NaV1.6, may play a role in helping to maintain
impulse conduction in depolarized hearts and that the
loss of NaV1.6 should result in a significantly greater
reduction of CV than in normally polarized hearts. In 8
WT and 9 null hearts (each heart measured twice), CV
was quantified at pacing CL of 140 ms in 4, 8, 10, and
12 mM [K]o, and at pacing CL of 80 ms in 4, 8, and 10
mM [K]o (Fig. 6). We do not have data during pacing
at 80 ms in 12 mM [K]o because 1:1 capture was lost.
Figure 6A presents activation maps that show an in-
creased time of conduction in null compared to WT
hearts during pacing at 140 ms in the presence of 12
mM [K]o. Figure 6B is a plot of CV (140 ms pacing
CL) as a function of [K]o. In both WT and null hearts,
increasing the [K]o between 4 and 10 mM resulted in
a similar biphasic change in CV. However, at 12 mM
[K]o, CV was 47.6  5.2 cm/s in WT vs. 36.5  3.1
cm/s in null hearts. This difference was significant
(P0.01, Mixed). Figure 6C is a plot of CV at pacing CL
of 80 ms. At 4 mM [K]o, CV was 56.2  8.8 cm/s in
WT vs. 53.1  3.1 cm/s in null; and at 8 mM CV
increased slightly in both groups of mice. However, at
10 mM [K]o, CV was 54.3 8.2 cm/s in WT vs. 46.3
3.1 cm/s in null hearts (P0.01, Mixed). These exper-
iments confirm the expected biphasic effects of hyper-
kalemia on CV (31). Most important, they demonstrate
that the absence of NaV1.6 causes a CV defect in the
presence of hyperkalemia. It is important to note that
due to the smaller number of animals in this experi-
mental subset (8 WT and 9 null), difference in CV was
not significant at 4 mM K compared to the significant
reduction we observed at 4 mM K in 16 WT and 17
null hearts described in the previous section.
Extracellular potassium and APD
We also quantified the effects of hyperkalemia on
APD80 (Fig. 7). Similarly to CV, APD80 was sampled
twice in 9 WT and 9 null hearts, at pacing CL of 140 ms
in 4, 8, 10, and 12 mM [K]o, and at pacing CL of 80 ms
in 4, 8, and 10 mM [K]o. The representative APD
maps in Fig. 7A show APD distributions on the anterior
wall of the ventricles of representative WT and null
hearts paced at CL  140 ms during 12 mM [K]o.
Figure 6. CV in hyperkalemia. A) Activation maps of WT and null hearts paced at 140 ms from the apex in 12 mM [K]o.
B, C) Plots of data in 9 WT and 9 null mice at different [K]o, with pacing at 140 (B) and 80 ms (C). Data are averages  sd,
Mixed.
Figure 7. APD80 in hyperkalemia. A) Anterior surface APD80 maps of WT and null hearts paced at 140 ms from the apex in 12
mM [K]o. B, C) Plot of data in 9 WT and 9 null mice at different [K
]o, with pacing at 140 (B) and 80 ms (C). Data are
averages  sd, Mixed.
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APD80 is prolonged in the null compared to WT hearts.
Figure 7B is a plot of APD80 at 140 ms pacing CL as a
function of [K]o. APD80 increased progressively in
both cases, but the increase was significantly steeper for
the null hearts. Figure 7C shows APD80 vs. [K
]o at
pacing CL of 80 ms.
NaV1.6 deletion alters Ca
2 transient duration
Brain-type Na channels, including NaV1.6, localize to
the t tubules of the ventricular myocyte (ref. 11 and Fig.
3). Some researchers have suggested that brain-type
sodium channels contribute to a more effective Ca2-
induced Ca2 release, and consequently to a more
efficient contraction, but the idea is controversial (12).
We compared the Ca2 transient duration in WT vs.
null myocytes during pacing at 1Hz. The left panel of
Fig. 8A shows the change in fluorescence along the
longitudinal red line on the cartoon of a myocyte.
Time-space plots (Fig. 8A, center panel) demonstrate
that the Ca2 transient duration is longer in the null
myocyte. The right panel of Fig. 8A shows superim-
posed Ca2 transient tracings obtained from single
camera pixels. The composite plot presented in Fig. 8B
quantifies the transient durations recorded in 26 cells
from 4 WT hearts (357108 ms) and 28 cells from 4
null hearts (45684 ms; P0.05, ANOVA). This exper-
iment shows that calcium cycling is altered in NaV1.6
mutant mouse hearts. Whether this is caused by APD
prolongation, or because removal of the Nav1.6 from
the t tubules causes inefficient and asynchronous cal-
cium cycling and consequently prolongs APD, remains
to be determined. Both scenarios are possible. It should
also be noted that recently Torres et al. (32) showed
that neuronal sodium channels contribute to triggering
Ca2 release from the sarcoplasmic reticulum in rabbit
ventricular myocytes.
DISCUSSION
The most important results of our study may be sum-
marized as follows: the NaV1.6 transcript encoding the
full-length protein is expressed in the mouse ventricles,
and the protein is localized mainly in the t tubules of
the myocyte; in the NaV1.6-null mice, ventricular myo-
cytes are smaller than in WT, and the TTX-sensitive
sodium current is significantly reduced; PR and QRS
intervals, as well as ventricular APD, are prolonged in
the null mice; at 4 mM [K]o, epicardial conduction
velocity is slightly reduced, but in hyperkalemia (10 and
12 mM [K]o) CV slowing is exaggerated in the null
mouse heart; and finally, the calcium transient dura-
tion is longer in the null than WT myocytes.
Altogether, the results strongly support the hypothe-
sis that NaV1.6 plays a role in excitation and propaga-
tion. Because of its larger availability at more positive
membrane potentials compared to the cardiac type
NaV1.5 isoform, NaV1.6 may contribute to maintaining
the integrity of the action potential propagation when
the resting membrane potential is depolarized, such as
in hyperkalemia. In addition, because of their localiza-
tion at the t tubules, NaV1.6 channels likely participate
in EC coupling by accelerating the depolarization of
the sarcolemmal membrane, and thus synchronizing
the calcium-induced calcium-release events.
NaV1.6 channels are encoded by the SCN8A gene,
which was originally identified by positional cloning of
a mouse mutant (33). When expressed in nonexcitable
cells in culture, the voltage-dependent activation and
fast inactivation properties of NaV1.6 are similar to
NaV1.2, but its voltage dependence of slow inactivation
is more positive than other brain-type Na channels
(22). Estimates using various pharmacologic strategies
indicate that between 5 and 8% of the total cardiac INa
originates from brain-type TTX-sensitive sodium chan-
nels in ventricular myocytes in mice (11, 20, 21), 11%
in rats, and 10% in dogs, (20), and 20% in cardiac
Purkinje cells in dogs (20). The Catterall laboratory
(11) has recorded neuronal Na current in cardiac
myocytes using a scorpion toxin activator of these
channels. However, to our knowledge, our study is the
first to focus on the specific role played by NaV1.6 in
cardiac electrical function using genetically altered
mice. Since brain-type sodium channels, particularly
NaV1.6, display a greater availability than NaV1.5 at
positive potentials (3) they are adequately suited to
maintain excitability in the more depolarized cardiac
muscle. This is clearly the case in isolated NaV1.6
mutant mice exposed to high extracellular potassium
concentrations (Fig. 6). In addition, it is reasonable to
surmise that the unusually large late component of the
sodium current of NaV1.6 (22) contributes to APD in
Figure 8. NaV1.6-null mice exhibit a prolonged Ca
2 tran-
sient. A) Left panel: time-space plot line. Center panel:
representative time-space plot of Rhod-2 fluorescence in WT
(top) and null mouse myocytes (bottom). Right panel: super-
imposed single-pixel recordings. B) Composite plot of Ca2
transients. Data are averages  sd, ANOVA.
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the heart. However, APD is prolonged in the null mice.
Such a counterintuitive prolongation may be brought
about by potassium-channel remodeling, such as the
transient outward current Ito, IKSlow, the sustained cur-
rent IKsus, or the inward rectifier current IK1. It could
also be a response to the prolonged Ca2 transient and
the activation of the Na-Ca exchange current.
Brain-type sodium channels and EC coupling
Maier et al. (11) demonstrated that nanomolar concen-
trations of TTX interfered with left ventricular contrac-
tile function. The researchers proposed that brain-type
sodium channels play a role in coupling depolarization
of the cell surface membrane to contraction. Torres et
al. (32) also suggested that neuronal sodium channels
are important for EC coupling in the rabbit ventricular
myocyte. Other researchers disagree (12). Our experi-
ments in NaV1.6 mutant mice clearly show a prolonga-
tion of the Ca2 transient duration (Fig. 8), indicating
some kind of EC coupling disruption. Additional work
is required to investigate these issues. The prolongation
of the calcium transient in the NaV1.6-null mice opens
new avenues for research into its underlying mecha-
nisms. It may be caused by delays in the triggering of Ca2
release (29), late-opening LCCs, slowly propagating calcium
induced calcium release waves, or slowed reuptake of cyto-
solic Ca2 due to changes in the SERCA pump, phospho-
lamban, or the sodium calcium exchanger.
Pathophysiological implications
TTX-sensitive brain-type Na channels appear to con-
tribute to automaticity of sinoatrial nodal cells of the
mouse heart and may have a role in sinoatrial dysfunc-
tion (13). Recently it was shown that NaV1.1 and NaV1.6
are the primary Na-channel subunits in the rat sinus
node and that heart failure results in their down-
regulation (14). Missense mutations of neuronal Na-
channel genes have been linked to epilepsy, chronic
pain, and migraine, and 700 mutants of Nav1.1 have
been identified in patients with epilepsy (4, 34, 35). In
many cases, the defect not only increases the late
component of the current in neurons but may also have
life-threatening consequences in the heart because of
prolongation of the QT interval (3), although no direct
link between LQT and neuronal sodium-channel mu-
tations has been made. It is interesting that QT prolon-
gation is thought to be a major mechanism leading to
sudden unexpected death in epilepsy (36). In addition,
ictal atrioventricular block is a common finding in
patients with epilepsy, and QT dispersion, a risk indi-
cator of cardiac arrhythmias, is significantly increased
on ECG of children with epilepsy (3). A heterozygous
null mutation of human NaV1.6 was identified in a
family with ataxia and cognitive impairment (5); how-
ever, it is not known whether the patients present a
cardiac phenotype. Our results provide the first direct
demonstration that a brain-type sodium-channel muta-
tion that results in severe ataxia in the mouse also has
cardiac consequences, including alterations in cardiac im-
pulse conduction and EC-coupling synchrony. Whether
those cardiac consequences are significant in patients with
equivalent brain-type mutations remains to be determined.
Limitations
Many differences exist between ion channels that un-
derlie the action potential waveforms in rodents and
humans, which calls for extreme caution before at-
tempting to extrapolate our results. Our analysis has
been restricted to very young mice because of the
lethality of the NaV1.6-null mutation at 3 wk of age
(18). In addition, the global NaV1.6-null mice may
exhibit secondary effects on the heart, such as lateral-
ization of connexin43, possible compensatory changes
in other neuronal sodium channels, or adaptive remod-
eling due to the decreased body size of the null mice.
For these reasons, development of a heart-specific
NaV1.6-KO mouse model should be valuable for con-
firming the cell-autonomous role of NaV1.6 in cardio-
myocytes and characterization of NaV1.6 deficiency in
the adult heart.
CONCLUSIONS
The demonstration that brain-type Na channels are
expressed in various proportions in the heart, and that
they contribute to function in most cardiac tissues,
including sinoatrial node, (13) ventricles (11, 12, 21),
and cardiac conduction system, (20) has opened new
and exciting pathways for research into the molecular
basis of cardiac excitability and arrhythmogenesis in
both cardiac and brain diseases. Characterization of
new models of brain-type ion-channel diseases in mice
offers unique opportunities to better understand the
molecular mechanisms of cardiac disease pathogenesis
associated with imbalances of specific ion-channel iso-
forms. Previous functional studies of the brain-type
channels in heart have relied on the pharmacological
distinction between cardiac and brain channels, (3),
based on the greater sensitivity of the brain channels to
TTX compared to the cardiac NaV1.5 channels. How-
ever, TTX sensitivity does not distinguish among the
brain channels NaV1.1, NaV1.3, and NaV1.6, all of which
seem to be expressed in the heart. Our demonstration
of a cardiac phenotype in NaV1.6-null mice provides the
first direct evidence for the importance of NaV1.6 in EC
coupling and in the maintenance of ventricular con-
duction velocity and possibly under conditions in which
the resting membrane potential is depolarized and
cardiac excitability is jeopardized.
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